Considering the various limitations associated with the conventional dosage forms,
nanotechnology is gaining increased attention in drug delivery particularly in respiratory …

Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics-
based approaches aimed to tackle pulmonary ailments in recent years. The current …

In recent years significant progress has been made to improve particle deposition in the
lung. However, the development of strategies to overcome the air–blood lung barrier is still …

Respiratory diseases are leading causes of death and disability in developing and
developed countries. The burden of acute and chronic respiratory diseases has been rising …

Like two sides of the same coin, nanotechnology can be both boon and bane for respiratory
medicine. Nanomaterials open new ways in diagnostics and treatment of lung diseases …

Background: Pulmonary drug delivery is attractive for both local and systemic drug delivery
as a non-invasive route that provides a large surface area, thin epithelial barrier, high blood …

Local administration of therapeutics by inhalation for treatment of lung diseases has the
ability to deliver drugs, nucleic acids and peptides specifically to the site of their action and …

It is reported that pulmonary fibrosis has become one of the major long-term complications of
COVID-19, even in asymptomatic individuals. Currently, despite the best efforts of the global …

Pulmonary tuberculosis is a highly prevalent respiratory disease that affects approximately a
quarter of the world's population. The drug treatment protocol for tuberculosis is complex …

With the development of nanotechnology and confronting the problems of traditional
pharmaceutical formulations in treating lung diseases, inhalable nano-formulations have …